BrightSpring Health Services, Inc. - Common Stock (BTSG)
18.13
-0.21 (-1.15%)
BrightSpring Health Services, Inc. is a leading provider of comprehensive health services that cater to the needs of individuals requiring specialized care, including those with complex health challenges
The company offers a wide range of services, such as home health care, hospice care, and rehabilitation services, aimed at enhancing the quality of life for patients while supporting their families. By employing innovative care solutions and integrating advanced technologies, BrightSpring focuses on delivering patient-centered approaches that promote independence and well-being within the comfort of their own homes or community settings. With a commitment to exceptional care and service delivery, BrightSpring Health Services plays a crucial role in the healthcare ecosystem, serving vulnerable populations and improving health outcomes.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 9.4%. This performance was disheartening since the S&P 500 held its ground.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including AdaptHealth (NASDAQ:AHCO) and its peers.
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 28.6% year on year to $3.05 billion. The company expects the full year’s revenue to be around $11.85 billion, close to analysts’ estimates. Its non-GAAP profit of $0.22 per share was in line with analysts’ consensus estimates.
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG)
will be announcing earnings results tomorrow before market open. Here’s what to expect.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how AdaptHealth (NASDAQ:AHCO) and the rest of the senior health, home health & hospice stocks fared in Q3.
Let’s dig into the relative performance of The Pennant Group (NASDAQ:PNTG) and its peers as we unravel the now-completed Q3 senior health, home health & hospice earnings season.
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Option Care Health (NASDAQ:OPCH) and its peers.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at senior health, home health & hospice stocks, starting with BrightSpring Health Services (NASDAQ:BTSG).
President Trump has spoken about implementing a family caregiver tax credit during his presidential campaign to ease the burden on caregivers, here's who gains.
BrightSpring will sell its Community Living business to Sevita for $835M in a deal set to close in 2025, boosting operational focus and revenue growth projections.
Jim Cramer doesn't recommend buying Dynatrace stock due to its high price. Canopy Growth is the best pot stock. BrightSpring, Illumina, and Bank of America also mentioned. Cramer recommends buying Palo Alto.
Health-care services provider BrightSpring, which is backed by private equity firm KKR, priced its initial public offering at $13, below a marketed range of $15 to $18 per share, before opening on Friday a dollar below that IPO price.
